Logo image of BLN.CA

BLACKLINE SAFETY CORP (BLN.CA) Stock Fundamental Analysis

Canada - TSX:BLN - CA0923821007 - Common Stock

7.38 CAD
+0.02 (+0.27%)
Last: 10/3/2025, 7:00:00 PM
Fundamental Rating

3

Overall BLN gets a fundamental rating of 3 out of 10. We evaluated BLN against 13 industry peers in the Electronic Equipment, Instruments & Components industry. BLN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BLN shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BLN has reported negative net income.
BLN had a negative operating cash flow in the past year.
In the past 5 years BLN always reported negative net income.
In the past 5 years BLN reported 4 times negative operating cash flow.
BLN.CA Yearly Net Income VS EBIT VS OCF VS FCFBLN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.00%, BLN is in line with its industry, outperforming 53.85% of the companies in the same industry.
Looking at the Return On Equity, with a value of -10.18%, BLN is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
ROA -5%
ROE -10.18%
ROIC N/A
ROA(3y)-27.21%
ROA(5y)-24.23%
ROE(3y)-67.04%
ROE(5y)-51.72%
ROIC(3y)N/A
ROIC(5y)N/A
BLN.CA Yearly ROA, ROE, ROICBLN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 61.77%, BLN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of BLN has grown nicely.
BLN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.27%
GM growth 5Y4.6%
BLN.CA Yearly Profit, Operating, Gross MarginsBLN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

BLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BLN has more shares outstanding
Compared to 5 years ago, BLN has more shares outstanding
BLN has a better debt/assets ratio than last year.
BLN.CA Yearly Shares OutstandingBLN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BLN.CA Yearly Total Debt VS Total AssetsBLN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

An Altman-Z score of 4.21 indicates that BLN is not in any danger for bankruptcy at the moment.
The Altman-Z score of BLN (4.21) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.14 indicates that BLN is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.14, BLN perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 4.21
ROIC/WACCN/A
WACC8.37%
BLN.CA Yearly LT Debt VS Equity VS FCFBLN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 2.32 indicates that BLN has no problem at all paying its short term obligations.
With a Current ratio value of 2.32, BLN perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
BLN has a Quick Ratio of 1.98. This is a normal value and indicates that BLN is financially healthy and should not expect problems in meeting its short term obligations.
BLN has a Quick ratio (1.98) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.98
BLN.CA Yearly Current Assets VS Current LiabilitesBLN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

7

3. Growth

3.1 Past

BLN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.87%, which is quite impressive.
The Revenue has grown by 20.78% in the past year. This is a very strong growth!
Measured over the past years, BLN shows a very strong growth in Revenue. The Revenue has been growing by 30.78% on average per year.
EPS 1Y (TTM)60.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)20.78%
Revenue growth 3Y32.83%
Revenue growth 5Y30.78%
Sales Q2Q%11.6%

3.2 Future

The Earnings Per Share is expected to grow by 25.75% on average over the next years. This is a very strong growth
Based on estimates for the next years, BLN will show a very strong growth in Revenue. The Revenue will grow by 21.69% on average per year.
EPS Next Y38.21%
EPS Next 2Y52.34%
EPS Next 3Y20.71%
EPS Next 5Y25.75%
Revenue Next Year18.21%
Revenue Next 2Y19.47%
Revenue Next 3Y29.63%
Revenue Next 5Y21.69%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BLN.CA Yearly Revenue VS EstimatesBLN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
BLN.CA Yearly EPS VS EstimatesBLN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 135.31, which means the current valuation is very expensive for BLN.
Based on the Price/Forward Earnings ratio, BLN is valued a bit cheaper than the industry average as 76.92% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of BLN to the average of the S&P500 Index (23.32), we can say BLN is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 135.31
BLN.CA Price Earnings VS Forward Price EarningsBLN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100

4.2 Price Multiples

BLN's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 247.8
BLN.CA Per share dataBLN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BLN's earnings are expected to grow with 20.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.34%
EPS Next 3Y20.71%

0

5. Dividend

5.1 Amount

No dividends for BLN!.
Industry RankSector Rank
Dividend Yield N/A

BLACKLINE SAFETY CORP

TSX:BLN (10/3/2025, 7:00:00 PM)

7.38

+0.02 (+0.27%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)09-11 2025-09-11/bmo
Earnings (Next)01-14 2026-01-14/amc
Inst Owners27.05%
Inst Owner ChangeN/A
Ins Owners3.04%
Ins Owner ChangeN/A
Market Cap641.40M
Analysts78.18
Price Target9.47 (28.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-107.45%
Min EPS beat(2)-182.88%
Max EPS beat(2)-32.01%
EPS beat(4)2
Avg EPS beat(4)-10.6%
Min EPS beat(4)-182.88%
Max EPS beat(4)100%
EPS beat(8)3
Avg EPS beat(8)-12.99%
EPS beat(12)5
Avg EPS beat(12)-9.78%
EPS beat(16)5
Avg EPS beat(16)-12.48%
Revenue beat(2)0
Avg Revenue beat(2)-5.28%
Min Revenue beat(2)-5.5%
Max Revenue beat(2)-5.05%
Revenue beat(4)1
Avg Revenue beat(4)-0.74%
Min Revenue beat(4)-6.38%
Max Revenue beat(4)13.97%
Revenue beat(8)3
Avg Revenue beat(8)0.05%
Revenue beat(12)4
Avg Revenue beat(12)-0.63%
Revenue beat(16)6
Avg Revenue beat(16)0.17%
PT rev (1m)1.56%
PT rev (3m)1.56%
EPS NQ rev (1m)-33.33%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)-30%
EPS NY rev (3m)-60%
Revenue NQ rev (1m)-3.86%
Revenue NQ rev (3m)-3.86%
Revenue NY rev (1m)-2.08%
Revenue NY rev (3m)-4.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 135.31
P/S 4.37
P/FCF N/A
P/OCF N/A
P/B 8.05
P/tB 8.75
EV/EBITDA 247.8
EPS(TTM)-0.09
EYN/A
EPS(NY)0.05
Fwd EY0.74%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS1.69
BVpS0.92
TBVpS0.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5%
ROE -10.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.77%
FCFM N/A
ROA(3y)-27.21%
ROA(5y)-24.23%
ROE(3y)-67.04%
ROE(5y)-51.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.27%
GM growth 5Y4.6%
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA 4.93
Cap/Depr 87.09%
Cap/Sales 4.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.32
Quick Ratio 1.98
Altman-Z 4.21
F-Score6
WACC8.37%
ROIC/WACCN/A
Cap/Depr(3y)111.77%
Cap/Depr(5y)105.56%
Cap/Sales(3y)8.6%
Cap/Sales(5y)9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y38.21%
EPS Next 2Y52.34%
EPS Next 3Y20.71%
EPS Next 5Y25.75%
Revenue 1Y (TTM)20.78%
Revenue growth 3Y32.83%
Revenue growth 5Y30.78%
Sales Q2Q%11.6%
Revenue Next Year18.21%
Revenue Next 2Y19.47%
Revenue Next 3Y29.63%
Revenue Next 5Y21.69%
EBIT growth 1Y65.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year142.56%
EBIT Next 3Y65.48%
EBIT Next 5Y44.01%
FCF growth 1Y72.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.81%
OCF growth 3YN/A
OCF growth 5YN/A